September 1, 2021 - August 31, 2026 - Uncovering the genetic mechanisms of the Chromosome 17q21.31 Tau haplotype on neurodegeneration risk in FTD and PSP , Co-Principal Investigator . Sponsor: NIH, Sponsor Award ID: U54NS123746
July 1, 2021 - June 30, 2026 - Investigating the Functional Impact of AD Risk Genes on Neuro-Vascular Interactions , Co-Principal Investigator . Sponsor: NIH, Sponsor Award ID: U01AG072464
September 5, 2018 - June 30, 2023 - The Psychiatric Cell Map Initiative: Connecting Genomics, Subcellular Networks, and Higher Order Phenotypes , Co-Principal Investigator . Sponsor: NIH, Sponsor Award ID: U01MH115747
September 30, 2018 - May 31, 2023 - Systematic elucidation of endosomal trafficking as a therapeutic opportunity in AD using CRISPR-based functional genomics , Principal Investigator . Sponsor: NIH, Sponsor Award ID: R01AG062359
September 30, 2016 - August 31, 2021 - Linking tau proteostasis with neuronal activity in FTD , Co-Investigator . Sponsor: NIH, Sponsor Award ID: U54NS100717
September 30, 2018 - June 30, 2020 - Uncovering mechanisms of selective vulnerability by CRISPR-based genetic screens , Principal Investigator . Sponsor: NIH, Sponsor Award ID: R56AG057528
September 30, 2015 - May 31, 2020 - Rewiring of the human protein homeostasis network in normal and disease contexts , Principal Investigator . Sponsor: NIH, Sponsor Award ID: DP2GM119139
August 1, 2015 - July 31, 2018 - Stress response networks in cancer: systematic mapping and therapeutic potential , Principal Investigator . Sponsor: NIH, Sponsor Award ID: R00CA181494
August 1, 2014 - July 31, 2015 - Stress response networks in cancer: systematic mapping and therapeutic potential , Principal Investigator . Sponsor: NIH, Sponsor Award ID: K99CA181494